<DOC>
	<DOCNO>NCT00993928</DOCNO>
	<brief_summary>RATIONALE : Following program us write material pre-recorded mp3 device may help improve sleep cancer survivor . It yet know home-based program effective improve sleep cancer survivor . PURPOSE : This randomized phase II trial compare two home-based program improve sleep cancer survivor .</brief_summary>
	<brief_title>Home-Based Programs Improving Sleep Cancer Survivors</brief_title>
	<detailed_description>OBJECTIVES : Primary - To compare efficacy two home-based sleep intervention therapy sleep-wake disturbance , measure sleep latency time fall back asleep initial sleep onset per sleep diary , baseline ( week 1 ) end week 7 cancer survivor . Secondary - To compare efficacy intervention therapy sleep-wake disturbance measure number awakening sleep , sleep quality , sleep difficulty , sleep latency baseline ( week 1 ) week 4 7 participant . - To compare efficacy intervention therapy sleep-wake disturbance measure percentage participant group show improve sleep per Pittsburgh Sleep Quality Index . - To compare effect intervention fatigue , mood disturbance , sleep , benefit , distress patient population . - To describe side effect associate intervention patient . - To describe patient practice habit adherence measure via sleep behavior record . - To explore symptom cluster patient population look distress mediate variable . ( Exploratory ) - To explore predictor sleep quality . ( Exploratory ) OUTLINE : This multicenter study . Patients stratify accord current ( ≥ 1 per week past 4 week ) pharmacological treatment , include anxiolytic , insomnia mood ( yes v ) , current pharmacologic treatment pain ( yes v ) , sleep difficulty period ( ≤ 1 month v &gt; 1 month ) , age ( ≤ 50 vs 51-70 v &gt; 70 year ) . Patients randomize 1 2 intervention group . - Group 1 : Participants receive home-based sleep intervention comprise Sleep Hygiene Education booklet , print stimulus-control guideline , instruction sleep restriction , guided-imagery pre-recorded mp3 device . Participants meet study personnel intervention refinement ask practice behavior consistent stimulus-control sheet , read sleep hygiene booklet one chapter per day 7 day first week , need study . They also instruct use CD , without headphone , quiet comfortable place without light 30 minute every day 6 week bedtime . Participants instruct go sleep wake time every day study intervention . - Group 2 : Participants receive home-based sleep intervention comprise Sleep Hygiene Education booklet , print stimulus-control guideline , pre-recorded mp3 device contain short story essay . Participants meet study personnel instruct practice behavior consistent stimulus control sheet , read sleep hygiene booklet , use CD group 1 . Participants instruct sleep restriction . They offer guided-imagery CD study completion . Patients complete Three-Day Sleep Behavior Record 3 consecutive day baseline week 4 7 study intervention . Patients also complete questionnaire Numeric Analog Sleep Pain Scale , daily use CD , Sleep Hygiene Practice , Pittsburgh Sleep Quality Index , Profile Mood States , Brief Fatigue Inventory , Distress Thermometer , Side-Effect Questionnaire , Subject Global Impression Change baseline , week 2 6 , completion study intervention .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Prior diagnosis cancer At least 2 month ≤ 24 month since complete curativeintent treatment ( chemotherapy , surgery , and/or radiotherapy ) Ongoing hormonal therapy ( i.e. , tamoxifen , aromatase inhibitor , casodex ) Concurrent trastuzumab maintenance rituximab allow Sleep difficulty define self report sleep latency ≥ 30 minute 3 7 night week wish therapeutic intervention , and/or self report wake first fall asleep able fall back asleep ≥ 30 minute 3 7 night week No history diagnosis primary insomnia ( patient medical record , define behavioral , cognitive , pharmacologic treatment ) &gt; 30 consecutive day year cancer diagnosis No active cancer ( i.e. , consider evidence disease ) No concurrent CNS malignancy No history diagnose sleep disorder ( i.e. , obstructive sleep apnea , restless leg , periodic leg movement disorder ) PATIENT CHARACTERISTICS : ECOG performance status 01 Availability CD player head earphone Ability complete questionnaires No uncontrolled chronic pain ( i.e. , pain score ≥ 4 Numeric Analogue Sleep Pain Scale ) No diagnosis major depression disorder , acute anxiety disorder , schizophrenia per medical record No hot flash interrupt sleep Not work overnight hour unable change schedule No emotional , psychological , physical state , accord physician and/or study personnel evaluation , would preclude adherence daily home intervention implementation PRIOR CONCURRENT THERAPY : See Disease Characteristics More 4 day since prior corticosteroid , include inhaled steroid , dose &gt; 2 day No prior experience guide imagery cognitive behavioral therapy insomnia No concurrent new herbal therapy Stable dose daily herbal supplement start ≥ 8 week study intervention allow Herbal tea herbs various drink product allow No concurrent treatment variable dos follow : Antidepressants Anxiolytics Pain medication ( include counter ad antiinflammatory pain reliever ) Pharmacologic treatment sleep/wake disturbance allow , must use 4 week study entry , use daily intermittently</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>fatigue</keyword>
	<keyword>sleep disorder</keyword>
	<keyword>cancer survivor</keyword>
</DOC>